XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 26, 2023
Mar. 27, 2022
Mar. 26, 2023
Mar. 27, 2022
Income Statement [Abstract]        
Revenue $ 3,869,569 $ 4,060,416 $ 14,221,259 $ 12,591,485
Cost of goods sold 2,197,237 2,243,791 7,835,743 6,820,190
Restructuring charges, net - cost of goods sold 66,720 0 66,720 0
Total cost of goods sold 2,263,957 2,243,791 7,902,463 6,820,190
Gross margin 1,605,612 1,816,625 6,318,796 5,771,295
Research and development 429,451 407,120 1,325,211 1,193,091
Selling, general, and administrative 193,500 217,408 632,922 675,735
Restructuring charges, net - operating expenses 40,408 0 40,408 0
Total operating expenses 663,359 624,528 1,998,541 1,868,826
Operating income 942,253 1,192,097 4,320,255 3,902,469
Other income (expense), net (3,331) (57,402) (74,660) (68,260)
Income before income taxes 938,922 1,134,695 4,245,595 3,834,209
Income tax expense (124,914) (112,917) (537,201) (437,857)
Net income $ 814,008 $ 1,021,778 $ 3,708,394 $ 3,396,352
Net income per share:        
Basic (in dollars per share) $ 6.03 $ 7.34 $ 27.28 $ 24.17
Diluted (in dollars per share) $ 6.01 $ 7.30 $ 27.20 $ 24.02
Number of shares used in per share calculations:        
Basic (in shares) 134,924 139,229 135,945 140,534
Diluted (in shares) 135,395 140,057 136,314 141,400